News & Articles

The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test

Dr. Clifton Ray discusses the potential of Nanotrap particles to advance extracellular vesicle research, and how his team is using them to break down barriers in isolation, screening, and disease diagnostics

Find out how CRISPR/Cas9 KO cell line technology can speed up target identification, validation, and pathway discovery with these insider insights

This support will contribute to the measures against COVID-19, following provision of medical equipment and supplies, employee donations, and loans through NPO

Testa Analytical Solutions has published a new applications report that demonstrates how DLS can be used as an effective analytical technique for analyzing virus particles in solution

AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design

Promega automated sample preparation solution added to CDC COVID-19 test protocol

The test is intended to expand availability of COVID-19 screening resources in central Ohio

Join us on Wednesday, August 5, to learn how in vitro models can enable a deeper understanding of T cell biology

Watch this on-demand webinar to learn how to enhance sample preparation for a range of complex microbiome samples

xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections

Whole-genome sequencing offers the ability to reduce pediatric diagnostic odysseys which cost at least $14 billion annually in the U.S.

Faster, more accurate diagnoses are critical with non-small cell lung cancer, which accounts for about 85 percent of all lung cancer cases

Partnership awarded Innovate UK Knowledge Transfer Partnership grant